Low-dose Aspirin Does Not Appear To Reduce Risk Of CV Events In Patients With Diabetes
Tuesday, November 18, 2008 - 20:49
in Health & Medicine
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type-2 diabetes, according to a new study. However, aspirin did significantly reduce the combination of fatal coronary and fatal cerebrovascular events.